"The weight loss landscape is changing dramatically, and trainers need more than science - they need strategies to best help their clients succeed" shared Natalie Mayslich, Chief Operating Officer of ISSA
Of the 20 papers included for the GLP-1 subsample, three studies included data from healthy participants, 10 included individuals with overweight and obesity, seven included individuals with T2D, four studies investigated GLP-1 in patients with gastric bypass, one included twins, and, one study included individuals with acquired hypothalamic damage
Wegovy contains the same active ingredient as Ozempic (semaglutide) at a higher dose
Ozempic is the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes indicated not only to improve blood sugar, along with diet and exercise, but also to reduce the risk of major cardiovascular events (MACE) such as heart attack, stroke, or death in those who are also at high risk for these events.1 Oral semaglutide for type 2 diabetes has been available as Rybelsus in a different formulation and set of doses
